Drugs Approved for Kidney Cancer
This page lists cancer drugs approved by the Food and Drug Administration (FDA) for kidney cancer. The list includes generic names and brand names. The drug names link to NCI’s Cancer Drug Information summaries. There may be drugs used in kidney cancer that are not listed here.
Drugs Approved for Renal Cell Cancer (RCC)
- Afinitor (Everolimus)
- Afinitor Disperz (Everolimus)
- Aldesleukin
- Alymsys (Bevacizumab)
- Avastin (Bevacizumab)
- Avelumab
- Axitinib
- Bavencio (Avelumab)
- Belzutifan
- Bevacizumab
- Cabometyx (Cabozantinib-S-Malate)
- Cabozantinib-S-Malate
- Everolimus
- Fotivda (Tivozanib Hydrochloride)
- IL-2 (Aldesleukin)
- Inlyta (Axitinib)
- Interleukin-2 (Aldesleukin)
- Ipilimumab
- Keytruda (Pembrolizumab)
- Lenvatinib Mesylate
- Lenvima (Lenvatinib Mesylate)
- Mvasi (Bevacizumab)
- Nexavar (Sorafenib Tosylate)
- Nivolumab
- Nivolumab and Hyaluronidase-nvhy
- Opdivo (Nivolumab)
- Opdivo Qvantig (Nivolumab and Hyaluronidase-nvhy)
- Pazopanib Hydrochloride
- Pembrolizumab
- Proleukin (Aldesleukin)
- Sorafenib Tosylate
- Sunitinib Malate
- Sutent (Sunitinib Malate)
- Temsirolimus
- Tivozanib Hydrochloride
- Torisel (Temsirolimus)
- Votrient (Pazopanib Hydrochloride)
- Welireg (Belzutifan)
- Yervoy (Ipilimumab)
- Zirabev (Bevacizumab)
Drugs Approved for Upper Tract Urothelial Cancer (UTUC)
Drugs Approved for Wilms Tumor and other Childhood Kidney Cancers